Professional Documents
Culture Documents
What We Do
FAMILY PLANNING
S T R AT E G Y O V E R V I E W
Family planning is a key part of the foundation's broader commitment to empowering women and improving
family health.
The Challenge
countries who don’t want to get pregnant lack access to change lives. Every woman and girl
deserves the chance to determine
contraceptives and voluntary family planning
her own future. Read women’s
information and services. Less than 20 percent of women
stories
in Sub-Saharan Africa and barely one-third of women in
South Asia use modern contraceptives. In 2012, an
estimated 80 million women in developing countries had More than 220 million women in
an unintended pregnancy; of those women, at least one in developing countries who don’t
want to get pregnant lack access to
four resorted to an unsafe abortion.
Significant challenges stand in the way of making contraceptives and voluntary family
contraceptives more widely available and accessible, planning information and services.
The Opportunity
Voluntary family planning is one of the most cost-effective investments a country can make in its
future. Every dollar spent on family planning can save governments up to 6 dollars that can be
spent on improving health, housing, water, sanitation, and other public services.
Our Strategy
The Bill & Melinda Gates Foundation’s Family Planning program is working to bring access to
high-quality contraceptive information, services, and supplies to an additional 120 million
women and girls in the poorest countries by 2020 without coercion or discrimination, with the
longer-term goal of universal access to voluntary family planning.
With our partners, we support national governments that have committed to the goals of FP2020
and are leading the development and implementation of their own country-specific plans.
Foundation support includes assessing family planning needs, particularly among the poorest
and most vulnerable populations; identifying access barriers and funding gaps; developing and
testing interventions; sharing evidence-based practices; promoting accountability through real-
time performance monitoring and data collection; and fostering coordination among
governments, partners, and donors.
We also work to increase funding and improve policies for family planning, create public-private
partnerships to expand contraceptive access and options, develop innovative and affordable
contraceptive technologies, and support further research to close knowledge gaps.
We are particularly committed to exploring how our family planning efforts can meet the needs
of young women and girls.
Areas of Focus
We work with countries that are committed to expanding access to high-quality, voluntary
family planning to reduce maternal and newborn mortality. Our deepest engagements are in
India and Nigeria. We also work with public and private partners and make selected
investments in Indonesia, Pakistan, Ethiopia, Kenya, and the Democratic Republic of the
Congo.
In francophone West Africa, we are core members of the Ouagadougou Partnership for
Family Planning, and support Senegal and Niger to implement supply and demand
approaches that can inform practice across countries in that region.
We work to keep family planning on the global agenda and to hold donors and developing
countries accountable for their commitments to support family planning. Our work in this
area includes grantmaking, direct advocacy, communications counsel and support, and
engagement with leaders.
To monitor changes in contraceptive use and help all FP2020 countries track annual
progress toward their goals and improve program performance, we are investing in rapid
surveys that will provide data on family planning use in 6- and 12-month intervals,
supplementing country-wide health surveys that provide data only every 3 to 5 years.
Some women do not access or use contraceptives for a variety of reasons, even when they
want to avoid pregnancy. They may have misconceptions about their risk of becoming
pregnant, or be deterred by the cost, inconvenience, or concerns about side effects. In some
cases, opposition from family members or a limited range of available methods can be a key
factor in non use.
PLAN A VISIT
Be Aware of Fraudulent Activity Contact Us Privacy & Cookies Notice Terms of Use Brand Guidelines